{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:59:11Z","timestamp":1791572351619,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016019","name":"Federal State of Thuringia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016019","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bmc.2021.116355","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:06:26Z","timestamp":1628395586000},"page":"116355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Evaluation of \u03b3-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors"],"prefix":"10.1016","volume":"46","author":[{"given":"Sigrid","family":"Schwarthoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrike","family":"Sager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Sch\u00e4tz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius M.","family":"Rohrbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihar","family":"Raztsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Robaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Gaube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Winckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2021.116355_b0005","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2019: Attitudes to dementia. Alzheimer\u2019s Disease International (ADI); 2019. https:\/\/www.alzint.org\/u\/WorldAlzheimerReport2019.pdf."},{"key":"10.1016\/j.bmc.2021.116355_b0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.bmc.2021.116355_b0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1056\/NEJMra040223","article-title":"Alzheimer\u2019s disease","volume":"351","author":"Cummings","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bmc.2021.116355_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer\u2019s disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.bmc.2021.116355_b0025","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2021.116355_b0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1567205054367838","article-title":"Cholinesterases: roles in the brain during health and disease","volume":"2","author":"Ballard","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.bmc.2021.116355_b0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1017\/S1461145705005833","article-title":"Targeting acetylcholinsterase and butyrylcholinesterase in dementia","volume":"9","author":"Lane","year":"2006","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.bmc.2021.116355_b0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0045","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3390\/ijms22042033","article-title":"The role of butyrylcholinesterase and iron in the regulation of cholinergic network and cognitive dysfunction in Alzheimer's disease pathogenesis","volume":"22","author":"Jasiecki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2021.116355_b0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s12640-013-9398-z","article-title":"Memantine and cholinesterase inhibitors: complementary mechanisms in the treatment of Alzheimer\u2019s disease","volume":"24","author":"Parsons","year":"2013","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bmc.2021.116355_b0055","doi-asserted-by":"crossref","first-page":"3267","DOI":"10.2147\/DDDT.S86463","article-title":"A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer\u2019s disease","volume":"10","author":"Deardorff","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bmc.2021.116355_b0060","doi-asserted-by":"crossref","first-page":"8S","DOI":"10.1177\/0091270006288734","article-title":"Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease","volume":"46","author":"Geerts","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2021.116355_b0065","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","article-title":"The efficacy and safety of memantine for the treatment of Alzheime\u0155s disease","volume":"17","author":"Matsunaga","year":"2018","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.bmc.2021.116355_b0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1358\/dot.2016.52.4.2479357","article-title":"Memantine and donepezil: a fixed drug combination for the treatment of moderate to severe Alzheimer\u2019s dementia","volume":"52","author":"Owen","year":"2016","journal-title":"Drugs Today (Barc)"},{"key":"10.1016\/j.bmc.2021.116355_b0075","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2165\/11591860-000000000-00000","article-title":"Combination therapy for Alzheimer\u2019s disease","volume":"28","author":"Patel","year":"2012","journal-title":"Drugs Aging"},{"key":"10.1016\/j.bmc.2021.116355_b0080","doi-asserted-by":"crossref","first-page":"6710","DOI":"10.1021\/acs.jmedchem.5b00958","article-title":"Evaluation of homobivalent carbolines as designed multiple ligands for the treatment of neurodegenerative disorders","volume":"58","author":"Otto","year":"2015","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0085","doi-asserted-by":"crossref","first-page":"13164","DOI":"10.1038\/srep13164","article-title":"Conjugates of gamma-Carbolines and Phenothiazine as new selective inhibitors of butyrylcholinesterase and blockers of NMDARs for Alzheimer Disease","volume":"5","author":"Makhaeva","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2021.116355_b0090","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2014.09.048","article-title":"Beta and gamma carboline derivatives as potential anti-Alzheimer agents: a comparison","volume":"87","author":"Otto","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0095","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1385\/JMN:20:3:369","article-title":"Acetylcholinesterase: a multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease","volume":"20","author":"Greenblatt","year":"2003","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.bmc.2021.116355_b0100","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0105","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study","volume":"22","author":"Rosenberry","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2021.116355_b0110","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0115","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1021\/ja058683b","article-title":"Conformational flexibility in the peripheral site of Torpedo californica acetylcholinesterase revealed by the complex structure with a bifunctional inhibitor","volume":"128","author":"Colletier","year":"2006","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2021.116355_b0120","article-title":"The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design","volume":"15405\u201315411","author":"Greenblatt","year":"2004","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2021.116355_b0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1021\/acs.jmedchem.5b01119","article-title":"Novel tacrine-benzofuran hybrids as potent multitarget-directed ligands for the treatment of Alzheimer's disease: design, synthesis, biological evaluation, and X-ray crystallography","volume":"59","author":"Zha","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0130","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1021\/jm060164b","article-title":"Complexes of alkylene-linked tacrine dimers with Torpedo californica acetylcholinesterase: binding of Bis5-tacrine produces a dramatic rearrangement in the active-site gorge","volume":"49","author":"Rydberg","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0135","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/jm200773h","article-title":"Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells","volume":"55","author":"Kalin","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2021.116355_b0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jlcr.2580230309","article-title":"Synthesis of deuterium labelled fluphenazine utilising borane reduction","volume":"23","author":"Sardessai","year":"1986","journal-title":"J Lab Comp Radiopharm"},{"key":"10.1016\/j.bmc.2021.116355_b0145","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/biof.1322","article-title":"Differential inhibition of human erythrocyte acetylcholinesterase by polyphenols epigallocatechin-3-gallate and resveratrol. Relevance of the membrane-bound form","volume":"43","author":"Salazar","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.bmc.2021.116355_b0150","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J Mol Biol"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089621003631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:13:55Z","timestamp":1760836435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089621003631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S0968089621003631"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116355","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of \u03b3-carboline-phenothiazine conjugates as simultaneous NMDA receptor blockers and cholinesterase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2021.116355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116355"}}